ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM. Zhang X, Zhang Z, Zhang Q, Zhang Q, Sun P, Xiang R, Ren G, Yang S.. Cell Death Dis. 2018;9(2):57.
Liposomal nanoparticles carrying anti-IL6R antibody to the tumour microenvironment inhibit metastasis in two molecular subtypes of breast cancer mouse models. Guo C, Chen Y, Gao W, Chang A, Ye Y, Shen W, Luo Y, Yang S, Sun P, Xiang R, Li N.. Theranostics. 2017;7(3):775-788.
ZEB1 induces ER-alpha promoter hypermethylation and confers antiestrogen resistance in breast cancer. Zhang J, Zhou C, Jiang H, Liang L, Shi W, Zhang Q, Sun P, Xiang R, Wang Y, Yang S.. Cell Death Dis. 2017;8(4):e2732.
Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer. Fang Y, Wang J, Wang G, Zhou C, Wang P, Zhao S, Zhao S, Huang S, Su W, Jiang P, Chang A, Xiang R, Sun P.. Oncotarget. 2017;8(16):26702-17.
ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3. Zhou C, Jiang H, Zhang Z, Zhang G, Wang H, Zhang Q, Sun P, Xiang R, Yang S.. Oncotarget. 2017;8(33):.
Sox2 communicates with tregs through CCL1 to promote the stemness property of breast cancer cells. Xu Y, Dong X, Qi P, Ye Y, Shen W, Leng L, Wang L, Li X, Luo X, Chen Y, Sun P, Xiang R, Li N.. Stem Cells. 2017;35(12):2351-2365.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.